Ms. Walmsley’s nomination will be voted on at Microsoft’s annual shareholders meeting in December. If elected, she will become the fifth woman on the tech giant’s 13-member board, up from just two in 2015, per CNBC.
The board’s other female members are Teri List-Stoll, executive vice president and CFO of Gap; Sandra Peterson, operating partner at Clayton, Dubilier & Rice; Penny Pritzker, founder and chair of PSP Partners and former U.S. secretary of commerce; and Padmasree Warrior, founder, president and CEO of Fable Group.
“Emma is an accomplished business leader who led major advances in research and development at GSK and will bring her significant insights and global experience to Microsoft,” John W. Thompson, Microsoft’s independent board chair, said in the filing. “We believe she will be a valuable addition to the board.”
More articles on health IT:
OSF HealthCare joins funding for precision medicine software startup InsightRX
Movers and shakers: 10 latest leadership changes affecting health IT
Epic CEO Judy Faulkner on ‘yes, if’ strategy behind company’s culture, success & 11 other health IT notes
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
